|
C4 Therapeutics, Inc. (CCCC) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
C4 Therapeutics, Inc. (CCCC) Bundle
¡Descubra C4 Therapeutics, Inc. (CCCC) Valor verdadero con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los cambios influyen en la valoración de C4 Therapeutics, Inc. (CCCC), todo dentro de una sola plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.4 | 33.2 | 45.8 | 31.1 | 20.8 | 22.2 | 23.7 | 25.4 | 27.2 | 29.1 |
| Revenue Growth, % | 0 | 55.25 | 37.93 | -32.08 | -33.25 | 6.96 | 6.96 | 6.96 | 6.96 | 6.96 |
| EBITDA | -30.6 | -62.9 | -78.8 | -124.3 | -122.1 | -22.2 | -23.7 | -25.4 | -27.2 | -29.1 |
| EBITDA, % | -142.91 | -189.46 | -172.2 | -399.68 | -588.28 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 2.7 | 2.8 | 2.9 | 7.6 | 7.7 | 4.0 | 4.2 | 4.5 | 4.9 | 5.2 |
| Depreciation, % | 12.81 | 8.56 | 6.35 | 24.35 | 37.28 | 17.87 | 17.87 | 17.87 | 17.87 | 17.87 |
| EBIT | -33.3 | -65.7 | -81.7 | -131.9 | -129.8 | -22.2 | -23.7 | -25.4 | -27.2 | -29.1 |
| EBIT, % | -155.72 | -198.02 | -178.55 | -424.03 | -625.55 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 90.5 | 371.7 | 309.3 | 337.1 | 253.7 | 22.2 | 23.7 | 25.4 | 27.2 | 29.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.6 | 4.5 | 5.7 | 1.5 | 11.8 | 4.8 | 5.2 | 5.5 | 5.9 | 6.3 |
| Account Receivables, % | 21.62 | 13.51 | 12.48 | 4.74 | 56.85 | 21.84 | 21.84 | 21.84 | 21.84 | 21.84 |
| Inventories | .0 | .0 | .0 | -61.0 | .0 | -4.4 | -4.7 | -5.1 | -5.4 | -5.8 |
| Inventories, % | 0.00000467705 | 0 | 0 | -196.04 | 0 | -20 | -20 | -20 | -20 | -20 |
| Accounts Payable | 5.4 | 5.7 | 4.5 | 1.2 | 1.4 | 2.8 | 3.0 | 3.2 | 3.4 | 3.7 |
| Accounts Payable, % | 25.19 | 17.12 | 9.84 | 3.77 | 6.97 | 12.58 | 12.58 | 12.58 | 12.58 | 12.58 |
| Capital Expenditure | -1.3 | -.7 | -1.3 | -5.5 | -1.7 | -1.6 | -1.8 | -1.9 | -2.0 | -2.1 |
| Capital Expenditure, % | -6.31 | -1.96 | -2.79 | -17.67 | -8.23 | -7.39 | -7.39 | -7.39 | -7.39 | -7.39 |
| Tax Rate, % | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 | -0.97551 |
| EBITAT | -34.1 | -65.1 | -83.8 | -130.1 | -131.1 | -22.1 | -23.6 | -25.3 | -27.0 | -28.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -31.9 | -62.5 | -84.6 | -66.2 | -196.1 | -7.0 | -21.0 | -22.4 | -24.0 | -25.7 |
| WACC, % | 14.92 | 14.91 | 14.92 | 14.91 | 14.92 | 14.92 | 14.92 | 14.92 | 14.92 | 14.92 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -63.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -26 | |||||||||
| Terminal Value | -203 | |||||||||
| Present Terminal Value | -101 | |||||||||
| Enterprise Value | -165 | |||||||||
| Net Debt | -56 | |||||||||
| Equity Value | -109 | |||||||||
| Diluted Shares Outstanding, MM | 50 | |||||||||
| Equity Value Per Share | -2.19 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real C4 Therapeutics (CCCC) financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the highlighted cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Quickly observe the effects of your inputs on C4 Therapeutics' valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for C4 Therapeutics, Inc. (CCCC).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to the biotech sector.
- Customizable Forecast Assumptions: Easily modify growth projections, capital expenditures, and discount rates relevant to C4 Therapeutics, Inc. (CCCC).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for C4 Therapeutics, Inc. (CCCC).
- Interactive Dashboard and Charts: Visual representations of key valuation metrics facilitate straightforward analysis for stakeholders.
How It Functions
- Download the Tool: Gain immediate access to the Excel-based C4 Therapeutics DCF Calculator.
- Enter Your Assumptions: Modify the yellow-highlighted cells for growth projections, WACC, profit margins, and additional parameters.
- Real-Time Calculations: The model automatically recalculates C4 Therapeutics’ intrinsic value.
- Explore Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Evaluate and Decide: Utilize the outcomes to inform your investment or financial assessments.
Why Choose This Calculator?
- User-Friendly Interface: Crafted for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
- Real-Time Feedback: Witness immediate updates to C4 Therapeutics, Inc.'s (CCCC) valuation as you modify inputs.
- Preloaded Data: Comes equipped with C4 Therapeutics, Inc.'s (CCCC) actual financial metrics for swift evaluation.
- Relied Upon by Experts: Employed by investors and analysts for making well-informed decisions.
Who Should Use This Product?
- Investors: Gain insights into potential investments with advanced analytics tailored for C4 Therapeutics, Inc. (CCCC).
- Pharmaceutical Analysts: Streamline your research with comprehensive data on drug development and market strategies.
- Healthcare Consultants: Efficiently modify reports and presentations to meet client needs in the biotech sector.
- Biotech Enthusiasts: Enhance your knowledge of therapeutic innovations with case studies from C4 Therapeutics, Inc. (CCCC).
- Academics and Students: Utilize this resource as a hands-on tool for studying pharmaceutical business models and strategies.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations specific to C4 Therapeutics, Inc. (CCCC).
- Real-World Data: C4 Therapeutics’ historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage tailored to C4 Therapeutics, Inc. (CCCC).
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results relevant to C4 Therapeutics, Inc. (CCCC).